These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31891387)

  • 1. Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    Parent-Michaud M; Dufresne PJ; Fournier E; Folch B; Martineau C; Moreira S; Doucet N; De Repentigny L; Dufresne SF
    J Antimicrob Chemother; 2020 Apr; 75(4):849-858. PubMed ID: 31891387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy.
    Prigitano A; Esposto MC; Grancini A; Passera M; Paolucci M; Stanzani M; Sartor A; Candoni A; Pitzurra L; Innocenti P; Micozzi A; Cascio GL; Delia M; Mosca A; Mikulska M; Ossi C; Fontana C; Pizzolante M; Gelmi M; Cavanna C; Lallitto F; Amato G; Vella A; Pagano L; Bandettini R; De Lorenzis G; Cogliati M; Romanò L; Tortorano A
    J Glob Antimicrob Resist; 2020 Sep; 22():231-237. PubMed ID: 32061880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azole resistance in Aspergillus isolates by different types of patients and correlation with environment - An Italian prospective multicentre study (ARiA study).
    Prigitano A; Esposto MC; Grancini A; Biffi A; Innocenti P; Cavanna C; Lallitto F; Mollaschi EMG; Bandettini R; Oltolini C; Passera M; De Lorenzis G; Sargolzaei M; Crespan M; Cogliati M; Tortorano AM; Romanò L
    Mycoses; 2021 May; 64(5):528-536. PubMed ID: 33438319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
    McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
    N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
    Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
    Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
    J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Azole Resistance and TR
    Güngör Ö; Sampaio-Maia B; Amorim A; Araujo R; Erturan Z
    Mycopathologia; 2018 Dec; 183(6):913-920. PubMed ID: 30187246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi.
    Van Rhijn N; Bromley M; Richardson M; Bowyer P
    mBio; 2021 Oct; 12(5):e0194521. PubMed ID: 34607450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies discrimination of A. fumigatus and siblings A. lentulus and A. felis of the Aspergillus section Fumigati using the AsperGenius
    Chong GM; Vonk AG; Meis JF; Dingemans GJ; Houbraken J; Hagen F; Gaajetaan GR; van Tegelen DW; Simons GF; Rijnders BJ
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):247-252. PubMed ID: 28007314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
    Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
    J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type.
    Duong TN; Le TV; Tran KH; Nguyen PT; Nguyen BT; Nguyen TA; Nguyen HP; Nguyen BT; Fisher MC; Rhodes J; Marks G; Fox GJ; Chen SC; Walsh MG; Barrs VR; Talbot J; Halliday CL; Sorrell TC; Day JN; Beardsley J
    Environ Microbiol; 2021 Dec; 23(12):7632-7642. PubMed ID: 34232541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithm to assess the presence of
    Viegas C; Almeida B; Aranha Caetano L; Afanou A; Straumfors A; Veríssimo C; Gonçalves P; Sabino R
    Int J Environ Health Res; 2022 May; 32(5):963-971. PubMed ID: 32814444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
    Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
    J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    Siopi M; Rivero-Menendez O; Gkotsis G; Panara A; Thomaidis NS; Alastruey-Izquierdo A; Pournaras S; Meletiadis J
    J Antimicrob Chemother; 2020 Nov; 75(11):3181-3188. PubMed ID: 32814940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three-year study period.
    Lucio J; Alcazar-Fuoli L; Gil H; Cano-Pascual S; Hernandez-Egido S; Cuetara MS; Mellado E
    Mycoses; 2024 Apr; 67(4):e13719. PubMed ID: 38551063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole-resistant Aspergillus fumigatus in the Italian environment.
    Prigitano A; Esposto MC; Romanò L; Auxilia F; Tortorano AM
    J Glob Antimicrob Resist; 2019 Mar; 16():220-224. PubMed ID: 30367993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.